chs.net (CYH): Price-to-Projected Revenue Ratio
Community Health Systems is expanding its clinic network, increasing its presence in promising US regions. The expected P/S multiple demonstrates a balance between market price and revenue forecasts, where 0.00 reflects the baseline level of the metric. Operating cash flow remains stable due to demand, although debt pressures liquidity. A cash cow model supports cash flow despite the debt load.
CYH (Community Health Corp): analytical breakdowns and indicator data
- stock price and consensus target price:
- stock exchange capitalization data:
- book value of equity indicators:
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Community Health Systems|CYH - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Community Health Systems|CYH - Aggregate Debt Obligations|Debts to Book Capitalization Community Health Corp|CYH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Community Health Systems|Quick Ratio chs.net
- financial results and valuation multiples details:
CYH - Net Profit|Expected Profit Community Health Systems|CYH - Price to Earnings Ratio|Projected Price to Earnings Community Health Systems Inc|CYH - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Community Health Corp|CYH - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Community Health Systems|CYH - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months chs.net|CYH - Expected net earnings per share growth this year|Expected earnings per share growth for next year Community Health Systems
- sales volume and revenue indicators:
Summary company analysis:Community Health Systems, Inc. CYH
For an investor in Community Health Systems (CYH), this indicator serves as a filter for market noise, allowing for an assessment of business value relative to expected sales volume amid the downsizing of the clinic network. By analyzing the forward P/S ratio, you can see the relationship between market capitalization and projected revenue, which helps distinguish speculative price growth from a genuine strengthening of the company's fundamental quality despite a high debt load.
Key competitors
HCA Healthcare - Forward Price-to-Revenue Multiple|Forward P/S Multiple Tenet Healthcare Corp THC|FMS - Price-to-Projected Revenue Ratio|SOLV (Solventum Health) - Market Cap to Projected Revenue|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple DVA|RDNT (RadNet Inc) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple OPCH (Option Care Health Inc)|SGRY - Market Cap to Future Revenue Ratio|Premier, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales EYE|Progyny - Forward P/S Multiple|Forward Price to Sales ARDT (Ardent Health)|SEM: Forward P/S Multiple|Market Cap to Future Revenue Ratio Astrana Corp (ASTH)|MD (Pediatrix Corp) - Forward P/S Multiple|Forward P/S Multiple US Physical Therapy Inc|Price-to-Projected Revenue Ratio The Pennant Group (PNTG)|Price-to-Projected Revenue Ratio ORGO (Organogenesis Holdings Inc.)|Nutex Health Corp - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AUNA (Auna Corp)|SBC Medical Corp - Forward P/S Multiple|Forward Price to Sales EOLS (evolus.com)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|MediWound - Forward Price to Sales|Price-to-Projected Revenue Ratio Biote Corp|The Joint (JYNT) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple DCGO (DocGo Inc.)|PIII - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Gain Therapeutics GANX|Market Cap to Expected Sales Ratio EUDA Health Holdings (EUDA)|BMGL: Forward Price-to-Revenue Multiple|CollPlant Biotechnologies - Price to Expected Revenue Ratio|CUPR: Forward P/S Multiple|Market Cap to Future Revenue Ratio concordmedical.com (CCM)|Price-to-Projected Revenue Ratio American Shared Hospital Services|Forward Price-to-Revenue Multiple MEDIROM Healthcare Group Inc. (MRM)|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|Market Cap to Expected Sales Ratio DIH Group|Forward P/S Multiple XAGE (Longevity Health Holdings)|NIVF - Forward Price-to-Revenue Multiple|ATIP: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio CareMax Inc.|KDLY: Forward P/S Multiple|ModivCare Corp - Forward Price to Sales|Forward Price-to-Revenue Multiple NVOS|SSY (SunLink Health Systems, Inc) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)
